Prichard S S
McGill University, Royal Victoria Hospital, Nephrology Division, Montreal, Quebec, Canada.
Nephrol Dial Transplant. 1997;12 Suppl 1:22-4.
In summary, Canada enjoys a publicly funded healthcare system which is the second most costly in the world. The treatment rate for renal replacement therapy is comparable with countries in Europe but falls short of that in the United States and Japan. With respect to costs, peritoneal dialysis is a cheaper option than haemodialysis. The major costs in peritoneal dialysis are supply related and the major costs in haemodialysis are labour and supplies. A treatment modality change includes a set of costs which makes the most cost-effective therapy in almost cases a therapy that can be successfully maintained.
总之,加拿大拥有一个由公共资金资助的医疗保健系统,其成本在世界上排名第二。肾脏替代疗法的治疗率与欧洲国家相当,但低于美国和日本。在成本方面,腹膜透析是比血液透析更便宜的选择。腹膜透析的主要成本与供应相关,而血液透析的主要成本是劳动力和供应。治疗方式的改变包括一系列成本,这使得在几乎所有情况下,最具成本效益的疗法是一种能够成功维持的疗法。